Early evaluation of corneal collagen crosslinking in ex-vivo human corneas using two-photon imaging
Abstract The clinical outcome of corneal collagen crosslinking (CXL) is typically evaluated several weeks after treatment. An earlier assessment of its outcome could lead to an optimization of the treatment, including an immediate re-intervention in case of failure, thereby, avoiding additional disc...
Main Authors: | Ana Batista, Hans Georg Breunig, Tobias Hager, Berthold Seitz, Karsten König |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-019-46572-3 |
Similar Items
-
High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea.
by: Yirui Zhu, et al.
Published: (2017-01-01) -
Thinner Corneas Appear to Have More Striking Effects of Corneal Collagen Crosslinking in Patients with Progressive Keratoconus
by: Yunfei Han, et al.
Published: (2017-01-01) -
Estimation of corneal thickness ex vivo and in vivo at instillation of photosensitizer solutions in different modifications of UV corneal crosslinking
by: M. M. Bikbov, et al.
Published: (2021-12-01) -
Corneal collagen crosslinking for keratoconus. A review
by: M. M. Bikbov, et al.
Published: (2014-10-01) -
Corneal collagen crosslinking in the treatment of infectious keratitis
by: Anwar HM, et al.
Published: (2011-09-01)